210 related articles for article (PubMed ID: 17380085)
1. [Daptomycin, the first cydal antibiotic of a new class active against Gram positive pathogens].
Stefani S; Esposito S
Infez Med; 2006 Dec; 14(4):179-96. PubMed ID: 17380085
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
Rybak MJ
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin: a new drug class for the treatment of Gram-positive infections.
Alder JD
Drugs Today (Barc); 2005 Feb; 41(2):81-90. PubMed ID: 15821781
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.
Steenbergen JN; Alder J; Thorne GM; Tally FP
J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644
[TBL] [Abstract][Full Text] [Related]
5. Pre-clinical experience with daptomycin.
Hawkey PM
J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii7-14. PubMed ID: 18829726
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin in the treatment of skin, soft-tissue and invasive infections due to Gram-positive bacteria.
Johnson A
Future Microbiol; 2006 Oct; 1(3):255-65. PubMed ID: 17661638
[TBL] [Abstract][Full Text] [Related]
7. Daptomycin - a novel antibiotic against Gram-positive pathogens.
LaPlante KL; Rybak MJ
Expert Opin Pharmacother; 2004 Nov; 5(11):2321-31. PubMed ID: 15500379
[TBL] [Abstract][Full Text] [Related]
8. [Daptomycin in the context of antimicrobial resistance in Gram-positive bacteria].
Candel González FJ
Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():10-6. PubMed ID: 22541970
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin.
Heidary M; Khosravi AD; Khoshnood S; Nasiri MJ; Soleimani S; Goudarzi M
J Antimicrob Chemother; 2018 Jan; 73(1):1-11. PubMed ID: 29059358
[TBL] [Abstract][Full Text] [Related]
10. The use of daptomycin for Staphylococcus aureus infections in critical care medicine.
Alder J
Crit Care Clin; 2008 Apr; 24(2):349-63, ix-x. PubMed ID: 18361950
[TBL] [Abstract][Full Text] [Related]
11. [Daptomycin: revitalizing a former drug due to the need of new active agents against grampositive multiresistant bacterias].
Hernández Martí V; Romá Sánchez E; Salavert Lletí M; Bosó Ribelles V; Poveda Andrés JL
Rev Esp Quimioter; 2007 Sep; 20(3):261-76. PubMed ID: 18080024
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin: a novel cyclic lipopeptide antimicrobial.
Schriever CA; Fernández C; Rodvold KA; Danziger LH
Am J Health Syst Pharm; 2005 Jun; 62(11):1145-58. PubMed ID: 15914875
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.
Kern WV
Int J Clin Pract; 2006 Mar; 60(3):370-8. PubMed ID: 16494659
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.
Kanafani ZA; Corey GR
Expert Rev Anti Infect Ther; 2007 Apr; 5(2):177-84. PubMed ID: 17402833
[TBL] [Abstract][Full Text] [Related]
15. [Daptomycin: pharmacological characteristics and its role in the treatment of gram positive infections].
Araos R; García P; Chanqueo L; Labarca J
Rev Chilena Infectol; 2012 Apr; 29(2):127-31. PubMed ID: 22689024
[TBL] [Abstract][Full Text] [Related]
16. Management of cSSTIs: the role of daptomycin.
Garau J
Curr Med Res Opin; 2006 Nov; 22(11):2079-87. PubMed ID: 17076967
[TBL] [Abstract][Full Text] [Related]
17. Daptomycin.
Enoch DA; Bygott JM; Daly ML; Karas JA
J Infect; 2007 Sep; 55(3):205-13. PubMed ID: 17629567
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin: a review 4 years after first approval.
Sauermann R; Rothenburger M; Graninger W; Joukhadar C
Pharmacology; 2008; 81(2):79-91. PubMed ID: 17940348
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin: pharmacology and clinical use.
Kosmidis C; Levine DP
Expert Opin Pharmacother; 2010 Mar; 11(4):615-25. PubMed ID: 20163272
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin: a review of properties, clinical use, drug delivery and resistance.
Vilhena C; Bettencourt A
Mini Rev Med Chem; 2012 Mar; 12(3):202-9. PubMed ID: 22356191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
